The ANA Mission

Represent, serve, and support the North American community of persons affected by aniridia and their families, patient advocacy organizations, and clinicians and scientists

ANIRIDIA North America

REPRESENT

SERVE

SUPPORT

ANA Vision

To assist North American aniridia-related patient advocacy organizations, coordinate with international organizations, strengthen and expand research, promote dissemination of information, and support clinical providers to improve outcomes for individuals with aniridia.

ANA Values

Fair representation for all aniridia-related stakeholders in North America, with meaningful, transparent, inclusive engagement.

Latest ANA News

The infographic presents the Strategic Plan for 2025 of Aniridia North America (ANA), an organization dedicated to representing, serving, and supporting individuals affected by aniridia, their families, patient advocacy organizations, clinicians, and scientists. Design & Structure: The top section features the ANA logo, with the organization's name inside an eye-shaped outline. "STRATEGIC PLAN 2025" is displayed in bold turquoise and white text. Below this, a mission statement in uppercase letters describes ANA’s goal of serving the North American aniridia community. Core Objectives (Displayed in a Honeycomb Layout): At the center of the infographic is the ANA logo, surrounded by six interconnected hexagons representing ANA’s 2025 strategic priorities: Increase EYEris Registry Enrollment (Black hexagon with "EYEris" logo) Focuses on expanding participation in the patient registry. Expand Patient & Family Advisory Board (Blue hexagon with an icon of people and a light bulb) Aims to enhance patient and family engagement in decision-making. Increase Outreach to Patients and Professionals (Gray hexagon with an icon of a presenter) Strives to improve awareness and engagement among patients and medical professionals. Create Strategic Fundraising Plan (Teal hexagon with a handshake and dollar symbol) Develops a structured approach to financial sustainability. Launch Focal Point Cornea Series (Light blue hexagon with a video chat icon) Introduces an educational series focused on corneal health in aniridia. Host ANA Aniridia Symposium (Teal hexagon with an icon of a presenter at a board) Plans to organize an event dedicated to discussions and advancements in aniridia research and treatment. Bottom Section: The website URL (aniridiaNA.org) is prominently displayed against a black background, encouraging viewers to visit for more information. This infographic effectively communicates ANA’s key initiatives for 2025 using a clear and visually appealing hexagonal layout.

2025 Strategic Plan

The ANA Board of Directors is looking forward to another great year in 2025. The infographic below highlights some goals set for…

A digital infographic titled "2024 In Review" summarizes the achievements of Aniridia North America (ANA) under three categories: Represent, Serve, and Support. Represent: ANA established a Medical Advisory Board, participated in the 7th European Aniridia Conference, and elected a patient representative to the Board of Directors. Serve: ANA presented preliminary results of a Neuropsychology Survey, launched the EYEris Aniridia Registry, and increased their online reach via website, Facebook, and YouTube. Support: ANA published a Patient Overview from the 2023 ANA Symposium, added Spanish-language resources to their website, and expanded their social media presence. At the bottom, ANA's mission is stated: "Represent, serve, and support the North American community of persons affected by aniridia and their families, patient advocacy organizations, and clinicians and scientists." The website aniridiaNA.org is displayed.

2024 Year In Review

Thank you to all who supported and donated to ANA in 2024. Thanks to your support, great things were achieved! The ANA Board of Directors is looking forward to another great year in 2025.

Here is a snapshot of the accomplishments from 2024 complete with links to information as appropriate.

What is Aniridia?

Aniridia is a rare genetic condition generally characterized by either the complete or partial absence of the iris, which is the colored part of the eye.

The word “aniridia” means “without iris”. The lack of iris is often the first and most noticeable feature of aniridia.

Aniridia can lead to complications with the eye including but not limited to:

  • glaucoma
  • cataracts
  • corneal keratopathy
  • strabismus
  • nystagmus
  • foveal hypoplasia

Aniridia and related complications present differently in each individual.

Recent research indicates that non-ocular conditions can also occur with aniridia. Some of these conditions include:

  • central auditory processing disorder
  • sleep disturbances
  • brain abnormalities
  • issues with the pancreas

Research is ongoing to better identify and understand these and other associated conditions.

Five hands, of varying shades and ages, are joined together.  Inside those hands it says "Join ANA" and shows the ANA logo.

Join ANA

Membership in ANA is free and open to anyone interested in aniridia. Whether you are a patient, family member, educator, clinician, scientist, or a patient advocacy organization, you are welcome here.

Sign up to receive updates and information from ANA. We know that alone we are rare, but together, we are strong.

North American Partner Organizations

ANA aims to augment the efforts of, facilitate interaction between, and provide support for groups and organizations focused on aniridia-related problems, with an inclusive approach and meaningful engagement. This includes coordinating and synergizing the efforts of these groups with similar international organizations.

Logo for the Vision for Tomorrow Foundation. It is a stylized blue eye with the name of the foundation underneath.
Global Genes Logo - Allies in rare Disease
Logo - Outline of an eye, with ANA in the middle and Aniridia North America underneath

Aniridia North America
106 W. Calendar Ave
Suite 122
LaGrange, IL 60525

Aniridia North America is registered as a 501(c)(3) non-profit organization in the United States.

EIN: 86-2917141

Resize text-+=